The European Commissioner for Health, Androulla Vassiliou, received a proposal from two of the three pharmaceutical companies producing the vaccine approved by the EU to reduce to a single dose recommendation, after taking these into account the results of scientific evidence demonstrating its effectiveness . The European Medicines Agency (EMEA) will consider this proposal and shall decide in coming days.
There is a video in the network starring by Teresa Forcades where this doctor and nun, lists the deficiencies associated with influenza A, explains the consequences of the declaration of PANDEMIC by WHO, the policy implications resulting therefrom, and makes a proposal to maintain calm as well as an urgent call to activate legal mechanisms and public participation in regard to this issue, all providing scientific data.
HRA Pharma , a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the United Kingdom via local HRA teams. HRA Pharma will progressively launch ellaOne in all European countries over the coming months.
Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today.